Peak6 LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Peak6 LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2025 Nov 13, 2025	SELL	$534.91 - $598.71 $8.56 Million - $9.58 Million	-16,000 Reduced 27.54%	42,100 $23.7 Million
Q2 2025 Aug 13, 2025	BUY	$483.07 - $625.6 $23.1 Million - $30 Million	47,900 Added 469.61%	58,100 $30.5 Million
Q1 2025 May 14, 2025	BUY	$634.14 - $744.83 $4.25 Million - $4.99 Million	6,700 Added 191.43%	10,200 $6.47 Million
Q4 2024 Feb 13, 2025	BUY	$701.85 - $1046.91 $2.46 Million - $3.66 Million	3,500 New	3,500 $2.49 Million

1,469

86.5M

2.38M

1.61M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 LLC with notifications on news.